Last reviewed · How we verify

NCT04892108

Rectal Prolapse With ODS. STARR vs LVR.

Completed NA Last updated 28 May 2021
What this trial tests

NA trial testing STARR (Stapled Trans Anal Rectal Resection) in Rectal Prolapse in 70 participants. Completed in 1 March 2021.

Timeline
1 January 2017
Primary endpoint
1 January 2019
1 March 2021

Quick facts

Lead sponsorUniversity Hospital of Ferrara
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment70
Start date1 January 2017
Primary completion1 January 2019
Estimated completion1 March 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital of Ferrara

Who can join

18 and older, female only, with Rectal Prolapse or Defecation Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study will be to evaluate the clinical and functional outcome of patients with obstructed defecation sndrome (ODS) associated to internal rectal prolapse, treated with transanal prolassectomy (STARR) surgery compared to those treated with laparoscopic ventral rectopexy (LVR).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Rectal Prolapse

Currently open trials in the same condition.

Other University Hospital of Ferrara trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04892108.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing